|
|
||||||||
Ann Thorac Surg 2002;74:1132-1137
© 2002 The Society of Thoracic Surgeons
B decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia
a Department of Surgery, Course of Interventional Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
b Department of Pathology, School of Allied Sciences, Faculty of Medicine, Osaka University, Osaka, Japan
Accepted for publication June 17, 2002.
* Address reprint requests to Dr Matsuda, Department of Surgery, Course of Interventional Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
e-mail: matsuda{at}surg1.med.osaka-u.ac.jp
BACKGROUND: The nuclear transcriptional factor NF
B is reported to play an important role in the expression of genes for neutrophil and macrophage chemotactic factors, adhesion molecules, and cell cycleregulating proteins. In aortocoronary bypass surgery, the saphenous vein often develops vein graft disease. Here, we investigated whether transfection of a cis element decoy oligodeoxynucleotide of NF
B (NF
B decoy) into the vein graft wall suppresses neointimal hyperplasia and the differentiation of medial smooth muscle cells.
METHODS: We established a canine aortocoronary bypass grafting model that has a saphenous vein graft between the left anterior descending coronary artery and the descending aorta. Pressure-mediated transfection of a scrambled (SD group; n = 5) or NF
B decoy (ND group; n = 5) into the graft wall was performed intraoperatively. The grafts were gently harvested at 4 weeks postoperative, and the middle portion of the graft was examined histopathologically.
RESULTS: The average neointimal area of the ND group was significantly suppressed (SD group, 2.63 ± 1.00 mm2 vs ND group, 0.88 ± 0.66, p < 0.05), and the differentiation and proliferation of the medial smooth muscle cells in the ND group were also suppressed (proliferating cell nuclear antigen index: SD group, 56 ± 24 vs ND, 13 ± 4, p < 0.05).
CONCLUSIONS: These results demonstrated the efficacy of intraoperative transfection of the NF
B decoy into the vein graft wall for attenuation of neointima formation.
This article has been cited by other articles:
![]() |
D. Xing, W. Feng, L. G. Not, A. P. Miller, Y. Zhang, Y.-F. Chen, E. Majid-Hassan, J. C. Chatham, and S. Oparil Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H335 - H342. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hinokiyama, G. Valen, S. Tokuno, J. B. Vedin, and J. Vaage Vein graft harvesting induces inflammation and impairs vessel reactivity. Ann. Thorac. Surg., October 1, 2006; 82(4): 1458 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schachner, G. Laufer, and J. Bonatti In vivo (animal) models of vein graft disease. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 451 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lehoux Redox signalling in vascular responses to shear and stretch Cardiovasc Res, July 15, 2006; 71(2): 269 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schachner Pharmacologic inhibition of vein graft neointimal hyperplasia J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1065 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. MANN Transcription Factor Decoys: A New Model for Disease Intervention Ann. N.Y. Acad. Sci., November 1, 2005; 1058(1): 128 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohmori, S.-i. Takeda, S. Miyoshi, M. Minami, S. Nakane, M. Ohta, Y. Sawa, and H. Matsuda Attenuation of lung injury in allograft rejection using NF-{kappa}B decoy transfection--novel strategy for use in lung transplantation Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 23 - 27. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |